1. Home
  2. IMMR vs ORGO Comparison

IMMR vs ORGO Comparison

Compare IMMR & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immersion Corporation

IMMR

Immersion Corporation

N/A

Current Price

$7.31

Market Cap

215.8M

Sector

Technology

ML Signal

N/A

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

N/A

Current Price

$1.40

Market Cap

181.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IMMR
ORGO
Founded
1993
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
215.8M
181.4M
IPO Year
1999
2016

Fundamental Metrics

Financial Performance
Metric
IMMR
ORGO
Price
$7.31
$1.40
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
★ $2.00
AVG Volume (30 Days)
294.4K
★ 534.3K
Earning Date
09-14-2026
11-05-2026
Dividend Yield
★ 4.15%
N/A
EPS Growth
N/A
★ 1600.00
EPS
★ 0.17
N/A
Revenue
$35,013,000.00
★ $564,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$37.55
P/E Ratio
$42.76
★ N/A
Revenue Growth
N/A
★ 17.04
52 Week Low
$5.25
$1.34
52 Week High
$8.05
$7.08

Technical Indicators

Market Signals
Indicator
IMMR
ORGO
Relative Strength Index (RSI) 46.04 31.90
Support Level $6.30 $1.34
Resistance Level $7.65 $2.55
Average True Range (ATR) 0.16 0.06
MACD -0.01 0.01
Stochastic Oscillator 38.74 17.65

Price Performance

Historical Comparison
IMMR
ORGO

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: